• Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • Chromosome Analysis, Amniotic Fluid
  • JAK2 (V617F) Gene Mutation Analysis
  • Thyroxine, Free (FT4)
  • Bordetella Pertussis Antibody, IgA
  • Alpha 1 Antitrypsin Genotyping/Phenotyping
  • Heroin, Urine
  • Alpha 2 Macroglobulin, Serum
  • PT and aPTT
  • Cytomegalovirus (CMV) Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Complement Component CH50
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Complement Component CH50
Medical Test

Methodology
Access to Complement Component CH50 is restricted.